Pulse Biosciences, Inc. Proceeds from Issuance of Debt
Pulse Biosciences, Inc. (PLSE) reported Proceeds from Issuance of Debt of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2023-03-31
- Pulse Biosciences, Inc. proceeds from issuance of debt for the quarter ending 2022-12-31 was -$65.00M.
- Pulse Biosciences, Inc. proceeds from issuance of debt for the quarter ending 2021-12-31 was $0.00.
- Pulse Biosciences, Inc. proceeds from issuance of debt for the quarter ending 2021-09-30 was $209.00K.
- Pulse Biosciences, Inc. proceeds from issuance of debt for the quarter ending 2021-06-30 was -$39.27M.
- Pulse Biosciences, Inc. proceeds from issuance of debt for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Pulse Biosciences, Inc. proceeds from issuance of debt for fiscal 2021 was $1.94M.
- Pulse Biosciences, Inc. proceeds from issuance of debt for fiscal 2020 was $0.00.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$65.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | ||
| 2022-09-30 | $65.00M 10-Q · filed 2022-11-10 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $209.00K derived: sum of 2 quarters · filed 2023-03-31 | -$39.06M derived: sum of 3 quarters · filed 2023-03-31 | $1.94M 10-K · filed 2023-03-31 |
| 2021-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$39.06M derived: sum of 2 quarters · filed 2022-11-10 | $1.94M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$39.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $1.73M 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $41.00M 10-Q · filed 2022-05-11 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |